A 2017 survey of physician assistants (PAs), data showed PAs are prescribing opioids and managing patients with pain in their practice; they’ve also expressed a need for education on both prescribing opioids and managing their patients with opioid use disorders – particularly in underserved populations.
In this free CME Snack, Dr. Gold and Ms. Catherine Judd share insights on best ways to approach opioid use while discussing the importance of gathering comprehensive patient histories – including substance use, integration of motivational interviewing, listening to patient stories, and the wellness aspect of treating patients with pain. It is imperative that clinicians set aside time to communicate thoroughly with patients about the medications they are being prescribed to avoid misuse and establish a positive patient-provider relationship.
At the end of this CME/CE activity, participants should be able to recognize the growing burden of the opioid epidemic and the role of physician assistants in addressing the opioid epidemic in their community.
The following learning objectives pertain only to those requesting CNE or CPE credit: Recognize the growing burden of the opioid epidemic and the role of physician assistants in addressing the opioid epidemic in their community.
Supported by an educational grant from Johnson & Johnson.
Physicians, physician assistants, nurse practitioners, nurses, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Gold has no disclosures to report.
Ms. Judd reports that she is on the speakers bureau for Alkermes; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; Sunovion Pharmaceuticals Inc. She is on the advisory board for ACADIA Pharmaceuticals Inc.; Neurocrine Biosciences, Inc.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.